12:00 AM
 | 
Mar 11, 2013
 |  BC Week In Review  |  Clinical News  |  Regulatory

RD-100i OSNA system regulatory update

The U.K.'s NICE issued draft guidance recommending Sysmex's RD-100i OSNA system to detect sentinel lymph node metastases in patients with early invasive breast cancer who have a sentinel lymph node biopsy...

Read the full 132 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >